AKAP10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.898000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.288000E-01
Normal-vs-Stage2
7.470400E-02
Normal-vs-Stage3
1.447990E-01
Normal-vs-Stage4
3.115800E-01
Stage1-vs-Stage2
4.109200E-01
Stage1-vs-Stage3
4.891600E-02
Stage1-vs-Stage4
6.900800E-01
Stage2-vs-Stage3
1.5259099999998E-05
Stage2-vs-Stage4
8.980200E-01
Stage3-vs-Stage4
1.574990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.564100E-02
Normal-vs-AfricanAmerican
3.480200E-01
Normal-vs-Asian
2.294400E-02
Caucasian-vs-AfricanAmerican
5.621600E-01
Caucasian-vs-Asian
7.421600E-02
AfricanAmerican-vs-Asian
9.863700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.407600E-02
Normal-vs-Female
1.235990E-01
Male-vs-Female
3.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.470600E-01
Normal-vs-Age(41-60Yrs)
1.664770E-01
Normal-vs-Age(61-80Yrs)
5.307600E-02
Normal-vs-Age(81-100Yrs)
6.193600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.721000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.762800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.868800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.395880E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.546000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.977200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.160040E-02
Normal-vs-Daily Drinker
1.947190E-01
Normal-vs-Weekly Drinker
6.229800E-02
Normal-vs-Occasional Drinker
1.549850E-01
Normal-vs-Social Drinker
1.811780E-01
Non Drinker-vs-Daily Drinker
3.219800E-01
Non Drinker-vs-Weekly Drinker
6.227400E-01
Non Drinker-vs-Occasional Drinker
1.144420E-01
Non Drinker-vs-Social Drinker
9.772200E-02
Daily Drinker-vs-Weekly Drinker
1.965990E-01
Daily Drinker-vs-Occasional Drinker
2.153900E-02
Daily Drinker-vs-Social Drinker
1.779800E-02
Weekly Drinker-vs-Occasional Drinker
3.998800E-01
Weekly Drinker-vs-Social Drinker
3.518400E-01
Occasional Drinker-vs-Social Drinker
9.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.303800E-01
Normal-vs-Grade 2
4.015400E-01
Normal-vs-Grade 3
7.491800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.654000E-01
Grade 1-vs-Grade 3
5.792200E-01
Grade 1-vs-Grade 4
5.303800E-01
Grade 2-vs-Grade 3
9.918200E-01
Grade 2-vs-Grade 4
4.015400E-01
Grade 3-vs-Grade 4
7.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.603530E-02
Normal-vs-NonDiabetic
4.635600E-02
Diabetic-vs-NonDiabetic
4.344000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.224600E-01
Normal-vs-NoPancreatitis
2.286100E-02
Pancreatitis-vs-NoPancreatitis
2.987000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.079980E-01
Normal-vs-N1
6.621800E-02
N0-vs-N1
8.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.240240E-01
Normal-vs-TP53-NonMutant
1.657180E-01
TP53-Mutant-vs-TP53-NonMutant
3.069400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
